These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 4465757

  • 21. [Response of primary nephrotic syndrome in children to corticosteroid treatment in the light of immunomorphological studies of the kidneys].
    Kozłowski J.
    Pediatr Pol; 1980 Jun; 55(6):715-22. PubMed ID: 7413320
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
    Norero C, Delucchi A, Lagos E, Rosati P.
    Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508
    [Abstract] [Full Text] [Related]

  • 24. [The combination of indomethacin and prednisone in the treatment of primary nephrotic syndrome in children].
    Creţu S, Mustafa E, Mustafa G.
    Rev Pediatr Obstet Ginecol Pediatr; 1980 May; 29(3):269-75. PubMed ID: 6781036
    [No Abstract] [Full Text] [Related]

  • 25. Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome.
    Mattoo TK, Mahmoud MA.
    Nephron; 2000 Aug; 85(4):343-5. PubMed ID: 10940745
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Contribution on the local application of corticosteroids].
    Schieferstein G.
    Z Haut Geschlechtskr; 1966 Nov 01; 41(9):354-63. PubMed ID: 5995307
    [No Abstract] [Full Text] [Related]

  • 34. [Prednisone and immunosuppressive agents in the therapy of nephrotic syndrome in infancy].
    Gabriele C, Gabriele S, Bandiermonte Z.
    Minerva Pediatr; 1971 Apr 21; 23(16):725-32. PubMed ID: 5555704
    [No Abstract] [Full Text] [Related]

  • 35. Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Eur J Pediatr; 1981 Feb 21; 135(3):229-37. PubMed ID: 7227377
    [No Abstract] [Full Text] [Related]

  • 36. [The influence of the initial prednisone treatment period on the adrenal function and the further course of the disease in steroid sensitive nephrotic syndrome in children].
    Ksiazek J.
    Pediatr Pol; 1995 Jan 21; 70(1):15-23. PubMed ID: 7624163
    [Abstract] [Full Text] [Related]

  • 37. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
    Abeyagunawardena AS, Trompeter RS.
    Arch Dis Child; 2008 Mar 21; 93(3):226-8. PubMed ID: 17573408
    [Abstract] [Full Text] [Related]

  • 38. Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation.
    Miao L, Sun J, Yuan H, Jia Y, Xu Z.
    Nephrology (Carlton); 2006 Oct 21; 11(5):449-54. PubMed ID: 17014560
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Glucocorticoids and bone mineral content in the childhood nephrotic syndrome.
    Cooper MS, Stewart PM.
    N Engl J Med; 2004 Dec 16; 351(25):2655-7; author reply 2655-7. PubMed ID: 15609419
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.